Inspire Medical Systems, Inc. Financials

Market Capitalization $3.79 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	58.94
Forward PE	64.89
Price to Sales TTM	$4.51
Price to Book MRQ	$5.96
Enterprise to Revenue	4.16
Enterprise to EBITDA	59.62

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	7.92%
Operating Margin	-0.74%
Return on Assets TTM	4.40%
Return on Equity TTM	10.86%

Income Statement

Revenue TTM	$840,110,976
Revenue per Share TTM	$28.21
Quarterly Revenue Growth	22.70%
Gross Profit TTM	$711,172,992
EBITDA	$80,963,000
Net Income to Common TTM	$66,506,000
Diluted EPS TTM	$2.18
Quarterly Earnings Growth YoY	%

Balance Sheet

Total Cash MRQ	$369,188,992
Total Cash per Share MRQ	$12.52
Total Debt MRQ	$
Total Debt to Equity MRQ	5.27
Current Ratio MRQ	9.01
Book Value per Share MRQ	$21.58

Cash Flow

Operating Cash Flow TTM	$114,683,000
Levered Free Cash Flow TTM	$42,409,248

INSP Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	29,740,176
Float Shares	29,036,768
Avg 10 Volume	514,880
Avg 30 Volume	None
Shares Short	3,398,569
Short Ratio	6.28
Short % of Shares	15.49%
% Held by Insiders	1.11%
% Held by Institutions	119.02%

Stock Price Summary

Beta	1.29
Fifty Two Week Low	$123.00
Fifty Two Week High	$225.00
Fifty Two Week Change	-9.64%
Day 50 MA	$142.96
Day 200 MA	$174.80

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date